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ABSTRACT
Objective The aim of this systematic review and
meta-analysis was to quantify the efficacy of cervical cer-
clage in preventing preterm birth (PTB) in asymptomatic
singleton pregnancies with a short mid-trimester cervi-
cal length (CL) on transvaginal sonography (TVS) and
without prior spontaneous PTB.
Methods Electronic databases were searched from incep-
tion of each database until February 2017. No language
restrictions were applied. All randomized controlled trials
(RCTs) of asymptomatic singleton pregnancies without
prior spontaneous PTB, found to have short CL < 25 mm
on mid-trimester TVS and then randomized to manage-
ment with either cerclage or no cerclage, were included.
Corresponding authors of all the included trials were
contacted to obtain access to the data and perform a
meta-analysis of individual patient-level data. Data pro-
vided by the investigators were merged into a master
database constructed specifically for the review. Primary
outcome was PTB <35weeks. Summary measures were
reported as relative risk (RR) with 95% CI. The qual-
ity of the evidence was assessed using the GRADE
approach.
Results Five RCTs, including 419 asymptomatic sin-
gleton gestations with TVS-CL < 25mm and without
prior spontaneous PTB, were analyzed. In women
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who were randomized to the cerclage group compared
with those in the control group, no statistically sig-
nificant differences were found in PTB < 35 (21.9%
vs 27.7%; RR, 0.88 (95% CI 0.63–1.23); I2 = 0%;
five studies, 419 participants), < 34, < 32, < 28 and
< 24weeks, gestational age at delivery, preterm prela-
bor rupture of membranes (PPROM) and neonatal
outcomes. In women who received cerclage compared
with those who did not, planned subgroup analyses
revealed a significantly lower rate of PTB <35weeks
in women with TVS-CL <10 mm (39.5% vs 58.0%;
RR, 0.68 (95% CI, 0.47–0.98); I2 = 0%; five studies;
126 participants) and in women who received tocolytics
(17.5% vs 32.7%; RR, 0.54 (95% CI, 0.31–0.93);
I2 = 0%; four studies; 169 participants) or antibiotics
(18.3% vs 31.5%; RR, 0.58 (95% CI, 0.33–0.98);
I2 = 0%; three studies; 163 participants) as additional
therapy to cerclage. The quality of evidence was down-
graded two levels because of serious imprecision and
indirectness, and therefore was judged as low.
Conclusions In singleton gestations without prior spon-
taneous PTB but with TVS-CL < 25 mm in the second
trimester, cerclage does not seem to prevent preterm deliv-
ery or improve neonatal outcome. However, in these
pregnancies, cerclage seems to be efficacious at lower
CLs, such as < 10 mm, and when tocolytics or antibi-
otics are used as additional therapy, requiring further
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studies in these subgroups. Given the low quality of
evidence, further well-designed RCTs are needed to con-
firm the findings of this study. Copyright© 2017 ISUOG.
Published by John Wiley & Sons Ltd.
INTRODUCTION
Preterm birth (PTB) is a major cause of perinatal morbidity
and mortality1. Worldwide, about 15 million babies are
born too early every year, resulting in 1.1 million deaths
as well as short- and long-term disabilities in countless
numbers of survivors2,3.
Few prognostic tests are available to predict PTB4,5.
Short cervical length (CL) measured by transvaginal
sonography (TVS) has been shown to be a good
predictor of spontaneous PTB in both singleton and twin
gestations4–8.
Different strategies have been adopted for preventing
PTB, including use of progesterone, cerclage and cer-
vical pessary, as well as lifestyle modification, such as
smoking cessation, diet, aerobic exercise and nutritional
supplements9–24. The evidence supports the use of
vaginal progesterone in singleton pregnancies with short
cervix9, while cervical cerclage seems to be beneficial
only in the subgroup of singleton gestations with
both prior spontaneous PTB and CL ≤ 25 mm10, but
not in singletons without prior PTB11 or in multiple
gestations24. Cervical pessary is relatively non-invasive
and easy to use, as it does not require anesthesia, it can
be inserted in an outpatient clinic setting and it can be
easily removed if necessary. However, published data
on the use of cervical pessary are contradictory, and
meta-analyses have shown that it has no efficacy in the
prevention of PTB in both singleton13 and multiple23
pregnancies.
Interestingly, only 235 women with singleton preg-
nancy without prior spontaneous PTB11 and 504 women
with singleton pregnancy and prior spontaneous PTB10
have been included in meta-analyses of randomized con-
trolled trials (RCTs) on cerclage for TVS-CL < 25 mm.
In an individual patient-level data (IPD) meta-analysis
of four RCTs, Berghella et al. found a non-significant
16% reduction in PTB <35 weeks in singletons without
prior spontaneous PTB but with a TVS-CL of < 25 mm
who were randomized to cerclage compared with no
cerclage11.
Recently, Otsuki et al. reported data from a new RCT
on cerclage in women with short TVS-CL, including also
singleton gestations without prior spontaneous PTB25.
They showed that for women with TVS-CL < 25 mm
between 16 and 26 weeks of gestation, cerclage might be
considered to reduce the occurrence of threatened PTB.
Our objective was to update and expand the previous
IPD meta-analysis11 and to evaluate the efficacy of cervical
cerclage in preventing PTB and perinatal morbidity and
mortality in asymptomatic singleton pregnancies with
short CL on mid-trimester TVS and without prior
spontaneous PTB.
METHODS
Search strategy
The review protocol was established by two investigators
(V.B. and G.S.) before commencement of the study
and was registered with the PROSPERO International
Prospective Register of Systematic Reviews (registration
no.: CRD42016048269).
The electronic databases MEDLINE, ClinicalTrials
.gov, PROSPERO and the Cochrane Central Register
of Controlled Trials were searched, from inception of
each database until February 2017, using the terms
‘cerclage’, ‘cervical cerclage’, ‘salvage cerclage’, ‘rescue
cerclage’, ‘emergency cerclage’, ‘ultrasound-indicated
cerclage’, ‘short cervix’, ‘cervical length’, ‘ultrasound’
and ‘randomized trial’. All manuscripts were reviewed
for pertinent references. No language restrictions were
applied.
Study selection
Selection criteria included RCTs of asymptomatic single-
ton pregnancies without prior spontaneous PTB found to
have a mid-trimester CL < 25 mm on TVS and then ran-
domized to management with either cerclage (intervention
group) or no cerclage (control group). Quasi-randomized
trials (i.e. trials in which allocation was carried out
on the basis of a pseudo-random sequence, such as
odd/even hospital number or alternation of date of
birth), studies on multiple pregnancies24 and studies on
symptomatic women were excluded. Trials evaluating
history-indicated (prior spontaneous PTB) or physical
examination-indicated (second-trimester cervical dilata-
tion detected on physical examination) cerclage26, trials
on ultrasound-indicated (short TVS CL)10,11,27 cerclage
with prior spontaneous PTB, as well as studies on techni-
cal aspects of cervical cerclage28, were also excluded.
Data extraction and risk-of-bias assessment
The risk of bias in each included study was assessed
using the criteria outlined in the Cochrane Handbook
for Systematic Reviews of Interventions29. Seven domains
related to risk of bias were assessed in each included trial
because there is evidence that these issues are associated
with biased estimates of treatment effect: (domain 1)
random sequence generation; (domain 2) allocation
concealment; (domain 3) blinding of participants and
personnel; (domain 4) blinding of outcome assessment;
(domain 5) incomplete outcome data; (domain 6) selective
reporting; and (domain 7) other bias. Review authors’
judgments were categorized as ‘low risk’, ‘high risk’ or
‘unclear risk’ of bias29.
We contacted the corresponding authors of all included
RCTs to request access to the data and perform
a meta-analysis of IPD. The authors were asked to
supply anonymized data (without identifiers) about
patient baseline characteristics, experimental intervention,
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control intervention, co-interventions and prespecified
outcome measures for every randomly assigned subject
and were invited to become part of the collaborative
group with joint authorship of the final publication.
Data provided by the investigators were merged into a
master database constructed specifically for the review.
Data were checked for missing information, errors and
inconsistencies by cross-referencing the publications of the
original trials. Quality and integrity of the randomization
processes were assessed by reviewing the chronological
randomization sequence and pattern of assignment, as
well as the balance of baseline characteristics across
treatment groups. Inconsistencies or missing data were
discussed with the authors and corrections were made
when deemed necessary.
Quality of evidence
For this review, the quality of the evidence was assessed
using the GRADE approach in order to assess the quality
of the body of evidence relating to the primary and
secondary outcomes. The GRADEpro Guideline Develop-
ment Tool was used to import data from Review Manager
5.3 (The Nordic Cochrane Centre, Cochrane Collabora-
tion, Copenhagen, Denmark) in order to create ‘Summary
of findings’ tables. A summary of the intervention effect
and a measure of quality for each of the above outcomes
was produced using the GRADE approach. The evidence
can be downgraded from ‘high quality’ by one level for
serious (or by two levels for very serious) limitations,
depending on assessments for risk of bias, indirectness
of evidence, serious inconsistency, imprecision of effect
estimates or potential publication bias29.
Outcomes
Primary and secondary outcomes were established
a priori. The primary outcome was PTB < 35 weeks.
Secondary outcomes were: PTB < 37, < 34, <32, < 28
and < 24 weeks; gestational age at delivery; latency (time
from randomization to delivery); incidence of PPROM;
and neonatal outcomes, including birth weight (low if
< 2500 g or very low if < 1500 g), respiratory distress
syndrome, intraventricular hemorrhage (Grade 3 or Grade
4), sepsis, necrotizing enterocolitis, admission to neonatal
intensive care unit (NICU), length of stay in NICU and
neonatal death (i.e. death of a liveborn baby within the
first 28 days). The primary outcome (PTB<35 weeks) was
assessed according to different TVS-CL cut-offs (≤ 20,
≤ 15, <10 and < 5 mm) and according to race, type of
cerclage and additional therapy used.
Data analysis
The data analysis was completed independently by two
authors (V.B. and G.S.) using Review Manager 5.3.
The completed analyses were then compared and any
difference was resolved with review of the entire data
and independent analyses. IPD were analyzed using the
so-called two-stage approach. In this, the IPD are first
analyzed separately in each study to produce study-specific
estimates of relative treatment effect. A combined estimate
is then obtained in the second step by calculating
a weighted average (inverse error variance based)
of the individual estimates using methods analogous
to meta-analyses of aggregate data. Between-study
heterogeneity was explored using the I2 statistic, which
represents the percentage of between-study variation
that is caused by heterogeneity rather than chance.
Meta-analysis was performed using the random-effects
model of DerSimonian and Laird, to produce summary
treatment effects in terms of either relative risk (RR)
or mean difference (MD) with 95% CI. Potential
publication biases were assessed statistically using Begg’s
and Egger’s tests30. P < 0.05 was considered statistically
significant.
Characteristics of the included women obtained in
the merged database were analyzed using SPSS Statistics
version 19.0 (IBM Inc., Armonk, NY, USA). Data are
shown as mean ± SD or as n (%). Univariate comparisons
of dichotomous data were performed using the chi-square
or Fisher’s exact tests. Comparisons between groups were
performed using the t-test to test group means with SD. A
two-sided value of P < 0.05 was considered statistically
significant.
All review stages were conducted independently by two
reviewers (V.B. and G.S.). The two authors independently
assessed the electronic search, eligibility of the studies,
inclusion criteria, risk of bias, data extraction and data
analysis. Disagreements were resolved by discussion with
a third reviewer (A.C.).
The meta-analysis was reported following the Preferred
Reporting Item for Systematic Reviews and Meta-analyses
(PRISMA) statement31.
RESULTS
Study selection and population characteristics
A flowchart summarizing study identification and selec-
tion is shown in Figure 1. Five RCTs25,32–35, includ-
ing 419 asymptomatic singleton gestations with short
mid-trimester TVS-CL and without prior spontaneous
PTB, were included in the meta-analysis.
The overall risk of bias of the included trials was
low (Figure 2). All studies had a low risk of bias in
random sequence generation, incomplete outcome data
and selective reporting. Adequate methods for allocation
of women were used. All randomized women were
included in an intention-to-treat analysis. Given the
type of intervention, double-blinding was not feasible
and all trials were judged as high risk in performance
bias.
Publication bias, assessed using Begg’s and Egger’s
tests, showed no significant bias (P= 0.39 and P= 0.51,
respectively). Statistical heterogeneity between the studies
was low (I2 = 0%) with no inconsistency in the primary
and most of the secondary outcomes.
Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2017; 50: 569–577.
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Records screened
(n = 11475)
Full-text articles
assessed for eligibility
(n = 19)
Full-text articles excluded (n = 14)
•  History-indicated cerclage
      (n = 10)
•  Cerclage vs pessary (n = 1)
•  Different cerclage techniques
      (n = 1)
•  Only high-risk women
       included (n = 1)
•  Ultrasound-indicated cerclage
      vs progesterone (n = 1)
RCTs included in
qualitative synthesis
(n = 5)
RCTs included in quantitative
synthesis (meta-analysis)
(n = 5)
Records after duplicates
removed
(n = 11475)
Records identified through
database search
(n = 11922)
Records excluded based on title
or abstract
(n = 11456)
Figure 1 Flowchart summarizing inclusion of randomized
controlled trials (RCTs) in this systematic review.
The characteristics of the included trials are shown
in Table 1. All the included trials enrolled also women
with prior spontaneous PTB who were excluded from
the IPD meta-analysis. Multiple gestations were also
excluded. Therefore, the IPD was used in order to include
only singleton gestations without prior spontaneous
PTB.
Of the 419 women analyzed, 224 (53.5%) were
included in the cerclage group (intervention group) and
195 (46.5%) in the control (no-cerclage) group. Only
singleton gestations without prior spontaneous PTB and
with short cervix < 25 mm on TVS were analyzed. Most
of the included studies (four of five)25,32,33,35 defined
short cervix as CL < 25 mm on TVS, while To et al.34
defined this as TVS-CL ≤ 15 mm. Three trials32,33,35 used
only McDonald cerclage, To et al.34 used only Shirodkar
cerclage, while Otsuki et al.25 used either McDonald
or Shirodkar cerclage (Table 1). All studies used the
transvaginal approach for cerclage. None of the 419
women received progesterone.
In the study by Berghella et al.35, administration of
indomethacin (100 mg loading dose rectally, perioper-
atively, followed by 50 mg every 6 h for 48 h orally,
postoperatively) was left to the discretion of the obste-
trician, while antibiotics were not used. In the study
by Althuisius et al.33, all women in the cerclage group
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Althuisius (2001)33
Berghella (2004)35
Otsuki (2016)25
Rust (2001)32
To (2004)34
Figure 2 Risk of bias according to the Cochrane Handbook29 in
randomized controlled trials included in meta-analysis. Only first
author is given for each study. Risk of bias: , low; , unclear;
, high.
received perioperative antibiotics (amoxicillin/clavulanic
acid 1 g intravenously four times daily and metronida-
zole 500 mg intravenously three times daily for 24 h,
followed by amoxicillin/clavulanic acid 500 mg four times
daily and metronidazole 500 mg three times daily for 6
days, orally) and indomethacin suppository (100 mg, 2 h
before and 6 h after the operation). In the study by Rust
et al.32, before randomization, all women were placed on
inpatient bed rest for 48–72 h and were treated identi-
cally with amniocentesis, multiple urogenital cultures and
48–72 h of therapy with indomethacin (100 mg load-
ing dose rectally, followed by 50 mg orally every 6 h)
and clindamycin (900 mg intravenously every 8 h). No
interventions, including tocolytics, antibiotics and bed
rest, were recommended routinely in the study by To
et al.34. In the study by Otsuki et al.25, all women ran-
domized in the cerclage group received tocolytic agents
(usually ritodrine 100 μg/min intravenously until the day
after the operation and for no longer than 2 days) and
ampicillin (2 g/day for 2 days). In the same trial, bed
rest was recommended for both groups for at least 7
days, and all patients were discharged from the hospi-
tal after 2 weeks from admission or operation25. Rust
et al.32, Althuisius et al.33, Otsuki et al.25 and Berghella
et al.35 routinely recommended similar activity restric-
tion for women in both the intervention and the control
groups.
Women who received cervical suture had it removed at
36 + 0 to 37 + 6 weeks of gestation, unless spontaneous
onset of labor, rupture of the membranes or need for early
delivery occurred.
In both groups, mean gestational age at randomization
was about 22 weeks (22.5 ± 2.0 weeks vs 22.2 ± 2.2
weeks) and mean TVS-CL was about 12 mm (12.6 ± 6.4
mm vs 12.7 ± 6.3 mm) (Table 2).
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Table 1 Characteristics of randomized controlled trials included in this systematic review and meta-analysis comparing effectiveness of use
of cervical cerclage vs no cerclage in preventing spontaneous preterm birth (PTB) in singleton pregnancies with short mid-trimester cervical
length (CL) on transvaginal sonography (TVS) and without prior spontaneous PTB
Reference Country
Sample
size (n)*
GA at
random-
ization
(weeks)
Definition
of short
TVS-CL
Type of
cerclage
Cerclage
suture
Definition
of prior
spontaneous
PTB (weeks)
Primary
outcome
Lost to
follow-up
(%)
Rust
(2001)32
USA 105
(51 vs 54)
16–24 <25 mm McDonald Permanent
monofilament
16–36 PTB
< 34 weeks
0
Althuisius
(2001)33
Netherlands 9
(5 vs 4)
14–27 <25 mm McDonald Braided tape 17–33 PTB
< 34 weeks
0
To
(2004)34
Multicenter† 209
(106 vs 103)
22–24 ≤ 15 mm Shirodkar Braided tape 16–32 PTB
< 33 weeks
0.4
Berghella
(2004)35
USA 21
(9 vs 12)
14–24 <25 mm McDonald Braided tape 16–34 PTB
< 35 weeks
0
Otsuki
(2016)25
Japan 75
(53 vs 22)
16–26 <25 mm McDonald
(n= 27),
Shirodkar
(n= 26)
Braided tape 16–36 GA at
delivery
0
Only first author is given for each study. *Cerclage group vs no-cerclage group. †UK, Brazil, South Africa, Slovenia, Greece and Chile. GA,
gestational age.
Table 2 Characteristics of 419 women with singleton pregnancy,
with short mid-trimester cervical length (CL) on transvaginal sono-
graphy (TVS) and without prior spontaneous preterm birth (PTB)
included in randomized controlled trials and randomized to man-
agement with cerclage or no cerclage to prevent spontaneous PTB
Cerclage No cerclage
Characteristicref (n = 224) (n = 195) P
Age (years)25,32–35 29.6 ± 6.3 29.7 ± 6.5 0.72
Prior cone33,35 3/14 (21.4) 4/16 (25.0) 0.58
Race32–35 0.75
White 95/171 (55.6) 88/173 (50.9)
Black 57/171 (33.3) 68/173 (39.3)
Other* 19/171 (11.1) 17/173 (9.8)
Mullerian anomalies33,35 1/14 (7.1) 0/16 (0.0) 0.44
Smoking25,33–35 18/173 (10.4) 16/141 (11.3) 0.70
GA at randomization
(weeks)25,32–35
22.5 ± 2.0 22.2 ± 2.2 0.27
CL on TVS (mm)25,32–35 12.6 ± 6.4 12.7 ± 6.3 0.93
Mode of delivery25,33–35 0.08
Vaginal 135/173 (78.0) 122/141 (86.5)
Cesarean section 38/173 (22.0) 19/141 (13.5)
Values are given as mean ± SD or n/N (%). *Asian, Hispanic. Some
data are missing as not all variables were recorded in every data-
base. GA, gestational age.
Synthesis of results
No statistically significant differences were found for the
primary outcome (PTB < 35 weeks) (Table 3, Figure 3)
or the secondary outcomes (Table 3, Figure 4) comparing
women who were randomized to the cerclage group with
those who were randomized to the control group.
In women who received cerclage compared with those
who did not, planned subgroup analyses revealed a
significant decrease in PTB <35 weeks in women with
TVS-CL < 10 mm (39.5% vs 58.0%; RR, 0.68 (95% CI,
0.47–0.98)) (Table 4; Figure 5), women who were white
(22.1% vs 37.5%; RR, 0.59 (0.37–0.94)) and in those
who received tocolytics (17.5% vs 25.7%; RR, 0.61 (95%
CI, 0.38–0.98)) or antibiotics (18.3% vs 31.5%; RR, 0.58
(95% CI, 0.33–0.98)) as additional therapy to cerclage
(Table 4; Figure 6).
The quality of evidence was downgraded because of
serious imprecision (Table 3). Outcomes were imprecise
because studies included relatively few patients and few
events, and thus had wide confidence intervals around the
estimate of the effect, and because the optimal information
size was not reached. The quality of the evidence was also
downgraded another level because of serious indirectness
owing to different study designs.
DISCUSSION
Main findings
This IPD meta-analysis of five RCTs, including 419
women, showed that transvaginal cervical cerclage did
not reduce the rate of PTB or improve neonatal outcome
in asymptomatic singleton pregnancies with mid-trimester
TVS-CL < 25 mm and without prior spontaneous PTB.
Planned subgroup analyses revealed a significant decrease
in PTB < 35 weeks in women with TVS-CL < 10 mm and
when tocolytics or antibiotics were used as additional
therapy.
The quality level of summary estimates was judged
low, as assessed by GRADE, indicating that the true effect
may, or is even likely to, be substantially different from
the estimate of the effect.
Our data support earlier findings of a prior
meta-analysis by Berghella et al.11. This review showed
that cerclage did not prevent preterm delivery in the
overall population of singletons with short TVS-CL but
without prior spontaneous PTB.
Strengths and limitations
One of the strengths of this meta-analysis is that we
included all RCTs published so far on the topic, including
Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2017; 50: 569–577.
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Table 3 Primary and secondary outcomes of randomized controlled trials included in this systematic review and meta-analysis comparing
effectiveness of use of cervical cerclage vs no cerclage in preventing spontaneous preterm birth (PTB) in 419 singleton pregnancies with short
mid-trimester cervical length (CL) on transvaginal sonography (TVS) and without prior spontaneous PTB
Outcomeref
Cerclage
(n =224)
No cerclage
(n = 195) RR or MD (95% CI) I2 (%) Q-statistic
Quality of
evidence
PTB <35 weeks25,32–35 49/224 (21.9) 54/195 (27.7) 0.88 (0.63 to 1.23) 0 2.09 Low
PTB <37 weeks25,32–35 81/224 (36.2) 80/195 (41.0) 0.93 (0.73 to 1.18) 57 4.84 Low
PTB <34 weeks25,32–35 45/224 (20.1) 49/195 (25.1) 0.89 (0.63 to 1.27) 0 0.67 Low
PTB <32 weeks25,32–35 38/224 (17.0) 39/195 (20.0) 0.96 (0.64 to 1.42) 0 0.62 Low
PTB <28 weeks25,32–35 26/224 (11.6) 22/195 (11.3) 1.15 (0.68 to 1.93) 0 0.52 Low
PTB <24 weeks25,32–35 5/224 (2.2) 4/195 (2.0) 1.14 (0.36 to 3.63) 0 0.69 Low
GA at delivery (weeks)25,32–35 35.81 35.59 0.22 (–0.58 to 1.02) 0 2.02 Low
Latency (days)25,32–35 86.68 83.41 3.27 (–3.22 to 9.76) 50 8.14 Low
PPROM32,34,35 34/166 (20.5) 23/169 (13.6) 1.52 (0.94 to 2.46) 0 1.21 Low
Birth weight (g)25,32–35 2635 2540 94.65 (–146.23 to 335.53) 0 0.41 Low
LBW25,32–35 42/224 (18.8) 49/195 (25.1) 0.88 (0.44 to 1.74) 52 9.41 Low
VLBW25,32–35 22/224 (9.8) 21/195 (10.8) 0.97 (0.57 to 1.68) 0 0.84 Low
RDS33,35 2/14 (14.3) 2/16 (12.5) 1.33 (0.23 to 7.74) 0 1.34 Low
IVH33,35 1/14 (7.1) 0/16 (0.0) 3.90 (0.18 to 85.93) 0 1.27 Low
Sepsis33,35 2/14 (14.3) 2/16 (12.5) 1.33 (0.23 to 7.74) 0 0.67 Low
NEC33,35 0/14 (0.0) 0/16 (0.0) NA NA NA Low
NICU25,33,35 3/67 (4.5) 4/38 (10.5) 0.80 (0.26 to 2.47) 31 6.41 Low
LOS in NICU (days)33,35 25.2 14.9 10.30 (–27.35 to 47.95) 0 2.34 Low
Neonatal death25,32,33,35 7/118 (5.9) 6/92 (6.5) 1.08 (0.41 to 2.86) 0 1.21 Low
Values are given as mean or n/N (%), unless stated otherwise. Some data are missing as not all variables were recorded in every database.
GA, gestational age; IVH, intraventricular hemorrhage; LBW, low birth weight; LOS, length of stay; MD, mean difference; NA, not
applicable; NEC, necrotizing enterocolitis; NICU, neonatal intensive care unit; PPROM, preterm prelabor rupture of membranes; RDS,
respiratory distress syndrome; RR, relative risk; VLBW, very low birth weight.
Rust (2001)32
Berghella (2004)35
Total (95% CI)
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Figure 3 Forest plot for risk of preterm birth <35 weeks in 419 women with singleton pregnancy, short sonographic mid-trimester cervical
length and no prior spontaneous preterm birth (PTB), randomized to management with cerclage or no cerclage to prevent spontaneous PTB.
Only first author is given for each study.
studies of high quality and with a low risk of bias
according to the Cochrane risk-of-bias tools. To our
knowledge, this is the largest, most comprehensive and
most up-to-date meta-analysis published so far on this
topic. Statistical analysis showed no significant potential
publication bias, and intention-to-treat analysis was used.
The statistical heterogeneity within the studies was very
low. Moreover, patient-level data were used to explore
for heterogeneity and maternal factors, and to perform
subgroup analyses (Table 4).
The limitations of our study are inherent to the
limitations of the included RCTs. The TVS-CL cut-off
for intervention was different in the RCT by To et al.34
compared with the rest of the included studies. Different
techniques for cerclage were used among the included
RCTs, but there are no definitive data to prove superiority
of one technique over the other techniques and the
subgroup analysis on this issue failed to reveal any
significant differences. Progesterone, which is currently
recommended for women with short TVS-CL36, was not
used in any of the included trials. The use of pericerclage
tocolytics or antibiotics was not uniform in the included
RCTs. Furthermore, most of the included RCTs routinely
recommended bed rest in both the cerclage and the
control groups. So far, there is no evidence supporting
the use of bed rest at home or in hospital to prevent
preterm delivery37. In a secondary analysis of an RCT of
17-α hydroxyprogesterone caproate among nulliparous
Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2017; 50: 569–577.
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Figure 4 Incidence of spontaneous preterm birth (PTB) at <24,
<28, <32, <34, < 35 and < 37 weeks in women with singleton
pregnancy, short sonographic mid-trimester cervical length and no
prior spontaneous PTB, randomized to management with cerclage
( ) or no cerclage ( ). RR, relative risk.
Table 4 Subgroup analyses for primary outcome (preterm birth (PTB) < 35 weeks) in 419 women with singleton pregnancy, short
mid-trimester cervical length (CL) on transvaginal sonography (TVS) and without prior spontaneous PTB included in this systematic review
and meta-analysis
Subgroup Cerclage No cerclage RR (95% CI) I2 (%)
TVS-CL ≤ 20 mm (n= 349)25,32–35 47/188 (25.0) 51/161 (31.7) 0.79 (0.56 to 1.10) 0
TVS-CL ≤ 15 mm (n= 305)25,32–35 43/159 (27.0) 49/146 (33.6) 0.81 (0.57 to 1.13) 0
TVS-CL < 10 mm (n= 126)25,32–35 30/76 (39.5) 29/50 (58.0) 0.68 (0.47 to 0.98)* 0
TVS-CL < 5 mm (n= 48)25,32–35 15/27 (55.6) 15/21 (71.4) 0.79 (0.50 to 1.23) 0
White race (n= 183)32–35 21/95 (22.1) 33/88 (37.5) 0.59 (0.37 to 0.94)* 0
Black race (n= 125)32–35 18/57 (31.6) 20/68 (29.4) 1.07 (0.63 to 1.83) 0
Shirodkar cerclage (n= 257)25,34 29/132 (22.0) 32/125 (25.6) 0.86 (0.55 to 1.33) 0
McDonald cerclage (n= 185)25,32,33,35 20/87 (23.0) 29/98 (29.6) 0.78 (0.48 to 1.27) 0
Tocolytics and cerclage vs
no tocolytics and no cerclage (n= 254)25,32–35
20/114 (17.5) 40/140 (28.6) 0.61 (0.38 to 0.98)* 0
Tocolytics and cerclage vs
tocolytics and no cerclage (n = 169)25,32,33,35
20/114 (17.5) 18/55 (32.7) 0.54 (0.31 to 0.93)* 0
Antibiotics and cerclage vs
no antibiotics and no cerclage (n= 249)25,32–35
20/109 (18.3) 36/140 (25.7) 0.71 (0.44 to 1.66) 0
Antibiotics and cerclage vs
antibiotics and no cerclage (n= 163)25,32,33
20/109 (18.3) 17/54 (31.5) 0.58 (0.33 to 0.98)* 0
Values are given as n/N (%). Some data are missing as not all variables were recorded in every database. *Statistically significant. RR,
relative risk.
women with singleton gestations and mid-trimester
TVS-CL < 30 mm, Grobman et al. showed that activity
restriction increased the risk of PTB < 37 weeks38.
In one of the included trials25, women with genital
tract infection were excluded and the design of the
study allowed rescue cerclage for all arms when bulging
membrane was noted. The high number of subgroup
analyses and secondary outcomes may lead to high risk of
false-positive results. We also acknowledge that only one
trial25 was added in this meta-analysis compared with our
prior review11. However, in this new review, IPD were
used. An IPD analysis has several distinct advantages
over aggregate data meta-analysis (ADMA). IPD involves
the synthesis of individual-level data from the individual
trials and therefore allows for the verification of published
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Figure 5 Incidence of spontaneous preterm birth (PTB) <35 weeks
in women with singleton pregnancy, short cervical length (CL)
< 25, ≤ 20, ≤ 15, <10 and < 5 mm on transvaginal ultrasound and
no prior spontaneous PTB, randomized to management with
cerclage ( ) or no cerclage ( ). *Statistically significant. RR,
relative risk.
results. As IPD are available, an IPD meta-analysis allows
for more flexibility regarding the inclusion and exclusion
of individuals, and the choice of endpoints and sub-
groups, compared with ADMA. These subgroups showed
potential benefit when the CL is < 10 mm and when
tocolytics or antibiotics were used with cerclage. Given
the low number of included trials, while no differences
were found in patient characteristics available in the
databases, unknown confounders cannot be ruled out.
Interpretation
Our findings provide evidence that cerclage does not
prevent PTB in singleton gestations without prior
spontaneous PTB but with short mid-trimester TVS CL.
Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2017; 50: 569–577.
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Figure 6 Incidence of spontaneous preterm birth (PTB) < 35 weeks
in women with singleton pregnancy, short sonographic
mid-trimester cervical length and no prior spontaneous PTB,
randomized to management with cerclage ( ) or no cerclage ( )
and use or not of tocolytics or antibiotics as additional therapy.
*Statistically significant. RR, relative risk.
Subgroup analysis of women who had TVS-CL < 10 mm,
or received tocolytics or antibiotics as additional therapy
to cerclage, showed that cerclage may reduce the incidence
of PTB; well-powered trials should be carried out in
these groups of patients. Notably, there is evidence in the
literature that adjunctive perioperative tocolytics and/or
antibiotics might increase the efficacy of the cervical
cerclage39. Biological plausibility would support these
results, as there are several pathways to PTB and these
involve mechanical weakness of the cervix from prior
surgical procedures40 or other factors which could be
treated with cerclage, infection which could be treated
by antibiotics and uterine contractions which could be
treated by tocolytics.
Conclusions
In summary, based on these Level-1 data, at least
as used so far in these trials, there is no significant
association between cervical cerclage and lower incidence
of PTB in asymptomatic singleton gestations with short
mid-trimester TVS-CL and without prior spontaneous
PTB. Cerclage seems to be possibly efficacious at lower
CLs, such as < 10 mm, and when tocolytics or antibiotics
are used as additional therapy, requiring further studies in
these subgroups. Indeed, with a low number of included
women in our subgroup analyses, the ability to discern
differences in preterm delivery is impaired by Type-II
error. We observed that with 80% power and a= 0.05,
a sample size of 103 patients in each group, for a total
of 206 singleton gestations without prior spontaneous
PTB but with TVS-CL < 25 mm, is required to detect a
reduction in PTB <37 weeks from a 34% baseline risk
of women given vaginal progesterone41, based on the RR
of 0.54 with indomethacin, antibiotics and cerclage vs no
tocolysis, antibiotics or cerclage; a new RCT has been
initiated based on the above findings.
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Cerclaje para el c e´rvix corto observado mediante ecograf ı´a en gestaciones con feto u´nico sin
parto pret e´rmino esponta´neo previo: revis i o´n sistema´t ica y metaana´l is is de ensayos controlados
aleatorizados uti l izando datos individuales de pacientes
RESUMEN
Objetivo El objetivo de esta revisio´n sistema´tica y metaana´lisis fue cuantificar la eficacia del cerclaje cervical en la prevencio´n
del parto prete´rmino (PPT) en embarazos asintoma´ticos de feto u´nico con una longitud cervical (LC) corta a mitad de trimestre
observada en la ecografı´a transvaginal (ETV) y sin PPT esponta´neo previo.
Me´todos Se busco´ en bases de datos electro´nicas desde el inicio de cada base de datos hasta febrero de 2017. No se aplicaron
restricciones de idioma. Se incluyeron todos los ensayos controlados aleatorizados (ECA) de embarazos asintoma´ticos con feto
u´nico y sin PPT esponta´neo previo que en la ETV de mitad de trimestre presentaron una LC corta <25 mm y luego fueron
asignados al azar al manejo con cerclaje o sin cerclaje. Se contacto´ a los autores de correspondencia de todos los ensayos
incluidos para solicitar el acceso a los datos y llevar a cabo un metaana´lisis de los datos individuales de las pacientes. Los datos
proporcionados por los investigadores se agregaron a una base de datos maestra creada especı´ficamente para esta revisio´n. El
resultado primario fue el PPT < 35 semanas. Las medidas resumen se reportaron como el riesgo relativo (RR) con IC 95%. La
calidad de la evidencia se evaluo´ utilizando el planteamiento GRADE.
Resultados Se analizaron cinco ECA, que incluı´an 419 gestaciones asintoma´ticas de feto u´nico con ETV-LC <25 mm y sin PPT
esponta´neo previo. En las mujeres que fueron asignadas al azar al grupo de cerclaje, en comparacio´n con el grupo control, no
se encontraron diferencias estadı´sticamente significativas ni en el PPT de <35 (21,9% vs. 27,7%, RR 0,88 (IC 95% 0,63–1,23),
I2 = 0%; cinco estudios; 419 participantes), <34, <32, <28 y <24 semanas, ni en la edad gestacional en el momento del
parto, en la rotura prematura de membranas (PPROM, por sus siglas en ingle´s) o en los resultados neonatales. En las mujeres
a quienes se les hizo cerclaje (en comparacio´n con las que no se les hizo), los ana´lisis planificados de subgrupos revelaron una
tasa significativamente menor de PPT <35 semanas en mujeres con ETV-CL <10 mm (39,5% vs. 58,0%, RR 0,68 (IC 95%,
0,47–0,98), I2 = 0%; cinco estudios; 126 participantes) y en las mujeres que recibieron tocolı´ticos (17,5% vs. 32,7%, RR
0,54 (IC 95%: 0,31–0,93), I2 = 0%; cuatro estudios; 169 participantes) o antibio´ticos (18,3% vs. 31,5%, RR 0,58 (IC 95%,
0,33–0,98), I2 = 0%; tres estudios; 163 participantes) como terapia adicional al cerclaje. La calidad de la evidencia se rebajo´ en
dos niveles debido a la alta imprecisio´n y por ser de tipo indirecto, y por lo tanto se juzgo´ como baja.
Conclusiones En gestaciones con feto u´nico y sin PPT esponta´neo previo pero con ETV-LC <25 mm en el segundo trimestre,
el cerclaje no parece prevenir el parto prete´rmino ni mejorar el resultado neonatal. Sin embargo, en estos embarazos, el cerclaje
parece ser eficaz en LC inferiores, como las <10 mm, y cuando se usan tocolı´ticos o antibio´ticos como terapia adicional, lo que
requiere estudios adicionales en estos subgrupos. Dada la baja calidad de la evidencia, hacen falta ma´s ECA bien disen˜ados para
confirmar los hallazgos de este estudio.
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